USRM Insider Trading Activity and SEC Form 4 Filings
USRM insider trading summary
No open-market insider purchases or sales of U.S. Stem Cell, Inc. (USRM) have been reported on SEC Form 4 in the past 12 months.
Latest USRM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 17, 2017 | William P Murphy Jr | Director | Buy | $50K (1,799,614 @ $0.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.